Guide du parcours de soins : Bronchopneumopathie chronique obstructive

Objectives

This French care-pathway guide aims to improve the quality, safety and appropriateness of care for people with chronic obstructive pulmonary disease (COPD), particularly in community and general practice, across the continuum from prevention and diagnosis to severe disease, exacerbations, palliative care and end-of-life support.[1][2][3]It seeks to provide personalised, multidisciplinary care that addresses medical, psychological, social, occupational and carer needs as well as respiratory disease.[4][5]

• Prevent COPD progression by prioritising smoking cessation, reducing exposure to tobacco, cannabis, occupational and environmental risks, and supporting vaccination against influenza and pneumococcal disease.[6][5][7][8]
• Improve early recognition and diagnostic certainty by identifying symptoms and risk factors, using quality-assured post-bronchodilator spirometry, and distinguishing COPD from asthma and other conditions.[9][10][11][12]
• Assess severity, prognosis and needs multidimensionally, including airflow obstruction, breathlessness, exercise capacity, nutrition, exacerbations, oxygenation, quality of life, participation restrictions and comorbidities.[13][14][15]
• Prevent and control symptoms, reduce exacerbation frequency and severity, improve exercise tolerance and quality of life, and reduce mortality through pharmacological and non-pharmacological management.[5][16][17]
• Provide respiratory rehabilitation, regular physical activity, nutritional support and therapeutic patient education to strengthen autonomy, self-management and sustained behaviour change.[18][19][20][21]
• Ensure safe management of severe respiratory failure through specialist-led oxygen therapy, ventilation and consideration of advanced interventions, including lung-volume-reduction procedures and lung transplantation assessment.[22][23][24][25]
• Deliver early palliative and supportive care in advanced disease, including symptom relief, future-care planning, advance directives, trusted-person designation and support for relatives.[26][27][28]

Implementation

The guide uses an integrated, person-centred pathway coordinated principally by the general practitioner, or by the respiratory physician for very severe disease, with information sharing across community, hospital, social and medico-social services.[29][30]Its recommendations draw on post-2014 evidence, Haute Autorité de Santé assessments, and multidisciplinary expert and patient-association input; stronger evidence underpins treatment recommendations, while organisational proposals often reflect professional consensus.[3]

• Coordinate multidisciplinary care involving general practitioners, respiratory physicians, pharmacists, nurses, physiotherapists, dietitians, rehabilitation professionals, psychologists, social workers, occupational-health services, addiction specialists, patient associations and other specialists according to individual needs.[5][16][31]
• Use local organisational structures, including multidisciplinary health centres, primary-care teams, territorial professional health communities, territorial support platforms, respiratory-rehabilitation networks and community professional organisations.[16][32][33][34]
• Share relevant information through the Shared Medical Record, secure health messaging, liaison letters, personalised health-coordination plans and, where appropriate, digital coordination tools under the e-parcours programme.[32][35][34][36]
• Provide structured prevention and case-finding by systematically recording smoking status, assessing other exposures and symptoms, supporting cessation, and referring adults with compatible symptoms or risk factors for spirometry delivered by trained professionals.[6][9][10]
• Personalise stable-disease treatment through smoking cessation, vaccination, physical activity, nutrition, rehabilitation, appropriate inhaled medicines, inhaler-technique training, adherence support and management of comorbidities.[35][37][17]
• Develop written, explained and personalised exacerbation action plans that help patients and relatives recognise early worsening, adjust care within defined circumstances, seek professional advice and identify emergency symptoms.[38][39][40]
• Deliver respiratory rehabilitation through hospital, outpatient, community or home settings according to clinical severity, autonomy, preferences and service availability, with these locations considered equivalent in effectiveness when appropriately coordinated.[41][42][43]
• Embed therapeutic education throughout care by assessing needs and expectations, agreeing individual objectives, building practical self-management skills and periodically reassessing acquired competencies.[19][20][44][45]
• Organise escalation and discharge after exacerbations through severity-based decisions on community or hospital management, early rehabilitation assessment, medication reconciliation, clinical liaison and coordinated post-discharge appointments.[46][47][48][49]
• Monitor patients clinically through smoking status, symptoms, exacerbations, inhaler technique, adherence, weight and nutrition, physical activity, oxygenation, lung function, comorbidities, quality of life and carer needs.[35][50][31][30]Follow-up frequency is adapted to severity, with annual spirometry generally used for mild to severe disease and more intensive general-practice and respiratory-specialist review for severe disease.[50][31]
• Apply quality assurance to respiratory testing through trained operators, calibrated equipment, reproducible manoeuvres, documented procedures and continuing quality-control records.[51][52][53]
• Recognise that the guide identifies pathway-quality indicators developed within French health-system transformation work, but the supplied material does not define a consolidated indicator set, reporting timetable, audit method, implementation targets or formal accountability framework.[1][30]

Monitoring & Evaluation

Monitoring is principally clinical and patient-centred, covering diagnostic quality, disease severity, symptoms, functional capacity, exacerbations, treatment use, comorbidities, rehabilitation progress and self-management. Quality indicators for the chronic obstructive pulmonary disease care pathway were developed through France’s health-system transformation work, but the supplied extracts do not define these indicators or establish a consolidated national reporting and accountability framework.[1][13][30]

• Monitor diagnosis and lung function through quality-assured spirometry, including trained operators, reproducible manoeuvres, calibration, documented procedures and medical interpretation. Repeat testing where results are uncertain or physiological variation may affect interpretation.[10][11][51][52][53]
• Assess disease severity using airflow obstruction, breathlessness, exercise tolerance, oxygenation, nutritional status, quality of life, participation restrictions, smoking status, exacerbation history and comorbidities. Use tools including the modified Medical Research Council dyspnoea scale, six-minute walk test, COPD Assessment Test, VQ11 questionnaire and BODE score where relevant.[13][14][15][54][55]
• Record annual exacerbations and hospitalisations, monitor oxygen saturation and use blood-gas analysis when indicated by deterioration, hypoxaemia, hypercapnia or respiratory failure.[13][50][56][46]
• Review treatment response, adherence and inhaler technique at every consultation and at one and three months after treatment changes; reassess triple inhaled therapy after three months.[35][17][57][58]
• Monitor smoking status, dependence, motivation, relapse risk, withdrawal symptoms, mental health and co-use of alcohol, cannabis or other substances. Exhaled carbon-monoxide measurement may support smoking-cessation motivation with the patient’s agreement.[37][59][60]
• Document vaccination in the vaccination record or shared medical record, and monitor physical activity, exercise-related desaturation, weight, body mass index, appetite, involuntary weight loss and nutritional adherence.[8][61][62][63]
• Conduct structured rehabilitation assessment before and after programmes, including respiratory, exercise, psychological, nutritional, social and educational assessment. Follow-up booklets may record educational objectives, activity, nutrition, comorbidities and action plans.[41][21][64][65][66]
• Monitor long-term oxygen therapy and home ventilation through clinical effectiveness, safety, tolerance, equipment use and adherence. Oxygen prescriptions require early review within three months and then at least annual reassessment; ventilation follow-up is scheduled at one, three and six months after initiation.[67][23][68][69][70]
• Arrange severity-based follow-up, including annual lung-function testing for many patients and intensified general-practitioner and respiratory-specialist contact in severe disease. Following hospitalisation for decompensation, arrange general-practitioner review within one week and respiratory review within one to two months.[50][31][56][49]
• Support continuity through shared records, secure messaging, discharge documentation, coordination plans and multidisciplinary information-sharing. The extracts do not specify formal audit cycles, reporting timetables, surveillance datasets, named accountability bodies or quantified implementation targets beyond these clinical and organisational arrangements.[35][45][30][49]

Costing & Financing

The extracts provide limited financing information rather than a costed implementation plan. They report that direct annual chronic obstructive pulmonary disease costs rise substantially with severity, but do not specify a programme budget, public allocation, financing envelope, funding gap, resource-mobilisation target or economic evaluation for the care pathway.[2][71]

• Report average direct annual costs of €7,628 for the least severe disease and €20,747 for patients receiving oxygen therapy.[2]
• Provide 65% reimbursement for certain nicotine-replacement medicines, while varenicline is reimbursed for adults with strong tobacco dependence defined by a Fagerström score of at least 7. Pharmacists may provide exemption from advance payment.[59][60][72]
• Recognise occupational disease coverage at 100% through the occupational accident and disease branch, while initial long-term-condition exemption is granted for 10 years and may be renewed.[73]
• Exclude prescribed or delivered physical activity from health-insurance reimbursement except in territorial experiments. Financial support for dietetic care may be available through outpatient respiratory-rehabilitation networks or day hospitals, while coverage for dietitians and adapted physical-activity professionals varies across mutual insurers and care networks.[62][18][74][75]
• Limit fixed triple-therapy reimbursement to severe disease, and provide no adult reimbursement for an inhalation chamber under the applicable legislation.[57][58]
• Link financial support for multidisciplinary health structures from regional health agencies to conclusion of a multi-year objectives and resources contract.[33]
• Identify differences in convenience and cost between home oxygen sources without quantifying the amounts.[76]
• Note that psychological support is generally not covered by health insurance except in particular circumstances, and that social services should inform patients and carers about home-help service costs and operating arrangements.[77][31]